CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-02 | ACKERMANN CHRISTINA Director | Grant or award · Employee Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2021-05-19 | Guerard Frederic Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +660,000 | 660,000 | ||
| 2021-05-19 | Guerard Frederic Chief Executive Officer | Grant or award · Restricted Stock Units | +450,000 | 450,000 | ||
| 2021-05-19 | Zamiri Parisa Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +219,000 | 219,000 | ||
| 2021-05-19 | Zamiri Parisa Chief Medical Officer | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2021-05-19 | BREUIL ROBERT S Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +232,000 | 232,000 | ||
| 2021-05-19 | BREUIL ROBERT S Chief Financial Officer | Grant or award · Restricted Stock Units | +159,000 | 159,000 | ||
| 2020-12-08 | Zamiri Parisa Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-12-08 | Salain Daniel CTOO | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-12-08 | Guerard Frederic Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-12-08 | BREUIL ROBERT S Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2020-09-29 | Flynn James E 10% owner | Conversion | +1,422,406 | 1,422,406 | ||
| 2020-09-29 | Flynn James E 10% owner | Conversion | +1,422,406 | 1,422,406 | ||
| 2020-09-29 | Flynn James E 10% owner | Conversion | +291,467 | 1,713,873 | ||
| 2020-09-29 | Flynn James E 10% owner | Conversion | +291,467 | 1,713,873 | ||
| 2020-09-29 | Flynn James E 10% owner | Conversion | +291,467 | 291,467 | ||
| 2020-09-29 | Flynn James E 10% owner | Purchase | +1,562,500 | $16.00 | $25.0M | 1,853,967 |
| 2020-09-29 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −12,809,912 | 0 | ||
| 2020-09-29 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −12,809,910 | 0 | ||
| 2020-09-29 | Flynn James E 10% owner | Conversion · Series C Preferred Stock | −2,624,901 | 0 |
Page 27 of 29 · 565 trades